Ghebrekristos Y, Ahmed A, Beylis N, Singh S, et al. Xpert MTB/RIF Ultra-resistant and MTBDRplus-susceptible rifampicin results in
people with tuberculosis: utility of FluoroType MTBDR and deep sequencing. Antimicrob Agents Chemother 2025 Feb 7:e0167124. doi: 10.1128/aac.01671.
PMID: 39918315
![]() |
![]() |
![]() |